ArticleACS omega2025
Cholesterol Derivatives Regulate Adenylyl Cyclase 7 Activity by Binding CARC and CRAC Motifs in the Cytosolic Subunits.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transmembrane adenylyl cyclases (tmACs; ACs) are enzymes that synthesize cyclic AMP (cAMP), which is a key molecule in cellular signaling. Disruptions in AC activity can lead to long-term shifts in cAMP levels associated with various pathologies. In our study, we analyzed AC primary sequences and identified cholesterol-binding CARC and CRAC motifs located in conserved cytosolic regions, a surprising finding for motifs that are typically membrane-associated. Focusing on AC7, we mapped these motifs within its predicted structure and performed docking studies with cholesterol derivatives (hydrocortisone, dexamethasone, and 25-hydroxycholesterol). Our results showed that these molecules predominantly bind to the forskolin (FSK) binding site, which contains two CARC motifs. Using membranes overexpressing AC7, we observed that all three derivatives significantly decreased FSK-mediated AC7 activity by up to 55%. This suggests that cholesterol derivatives might interact with CARC and CRAC motifs to regulate AC7 function and underscore the potential of cholesterol derivatives as natural modulators as well as provide a compelling basis for future exploration of cholesterol derivatives as possible therapeutic regulators of AC7.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.